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Ludwig-Maximilians-University, Munich, GermanyABSTRACT Alpha-synuclein (aS) is a 140-amino-acid protein that is involved in a number of neurodegenerative diseases.
In Parkinson’s disease, the protein is typically encountered in intracellular, high-molecular-weight aggregates. Although aS is
abundant in the presynaptic terminals of the central nervous system, its physiological function is still unknown. There is strong
evidence for the membrane affinity of the protein. One hypothesis is that lipid-induced binding and helix foldingmaymodulate the
fusion of synaptic vesicles with the presynaptic membrane and the ensuing transmitter release. Here we show that membrane
recognition of the N-terminus is essential for the cooperative formation of helical domains in the protein. We used circular
dichroism spectroscopy and isothermal titration calorimetry to investigate synthetic peptide fragments from different domains
of the full-length aS protein. Site-specific truncation and partial cleavage of the full-length protein were employed to further char-
acterize the structural motifs responsible for helix formation and lipid-protein interaction. Unilamellar vesicles of varying net
charge and lipid compositions undergoing lateral phase separation or chain melting phase transitions in the vicinity of physio-
logical temperatures served as model membranes. The results suggest that the membrane-induced helical folding of the first
25 residues may be driven simultaneously by electrostatic attraction and by a change in lipid ordering. Our findings highlight
the significance of the aS N-terminus for folding nucleation, and provide a framework for elucidating the role of lipid-induced
conformational transitions of the protein within its intracellular milieu.INTRODUCTIONThe protein alpha-synuclein (aS) is known to be implicated
in both idiopathic and inherited forms of Parkinson’s disease
(PD) as well as in a number of other neurodegenerative
disorders (1–6). This protein was first recognized as the
major component of disease-associated intracytoplasmic
fibrillar deposits in specific types of neurons (Lewy bodies)
considered to be the pathological hallmark of sporadic PD
(7,8). In dilute solution, the intrinsically disordered state
of monomeric aS is characterized by a dynamic ensemble
of transiently interconverting conformations involving
a broad energy landscape (9). Molecular crowding in the
native intracellular environment may shift this dynamic
equilibrium in favor of a particular folded state. At higher
concentrations, there is a striking aggregation propensity
and—upon long-term incubation—fibrillar structures even-
tually form that bear remarkable resemblance to the intra-
cellular amyloid deposits encountered in PD. Three
single-site mutations of the aS protein are known to be asso-
ciated with inherited early-onset variants of PD (10–12).
These mutant proteins undergo accelerated oligomer forma-
tion, and two of them rapidly form large fibrillar structures
(13). A hydrophobic sequence domain, referred to as non-
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0006-3495/10/10/2116/9 $2.00role for nucleation of the aggregation process (14). In addi-
tion, the amino-acid sequence of aS is characterized by
seven imperfect repeats containing a KTKEGV consensus
motif (Fig. 1). Similar motifs are found in apolipoprotein
A-I, which forms amphipathic helices upon lipid-binding
(15–17). This is in line with the observation that the intrin-
sically disordered aS monomer undergoes a coil/helix
transition upon binding to small unilamellar vesicles
(SUVs) that feature a negatively charged lipid-water inter-
face (18) or interfacial packing defects (19). The amphi-
pathic nature of the aS N-terminus may play a role in
membrane interaction similar to rat endophilin N-BAR
domain (20,21), which may allow for curvature sensing
(22). Notable contributions for our recent understanding of
membrane interactions and of the conditions that promote
the misfolding and aggregation of aS have been provided
by Anthony Fink (23).
A variety of spectroscopic techniques have been em-
ployed to obtain high-resolution structural information on
the interface-associated state of the protein (24–29). Pulsed
electron spin resonance spectroscopy has provided evidence
for a continuous single helix when the protein is associated
with a flat lipid interface (26–28), in conformity with recent
computational work (30). Moreover, truncation of the
C-terminus results in accelerated aggregation of the protein
(31), indicating that the flexibility of the C-terminus may
result in stabilization of rapidly interconverting structures
in solution, thereby inhibiting aggregation (32). The
C-terminus has also been associated with age-related,doi: 10.1016/j.bpj.2010.06.035
FIGURE 1 Amino-acid sequence of a-synuclein.
TheN-terminal region is blue, the aggregation-prone
(NAC) domain is in green, and theC-terminal region
is in red. The seven imperfect repeats are indicated in
bold type. Protein fragments are schematically
shown as bars above (synthetic small peptides) or
below (chemically truncated protein). For clarity,
the N-terminal truncated mutants are omitted.
Membrane Folding of a-Synuclein 2117calcium-induced membrane interaction and subsequent
protein aggregation (33). The N-terminus confers toxicity
to the protein, while deletion of an N-terminal peptide not
only alleviates toxicity but also decreases the helix propen-
sity (34). Yet there are still unresolved questions regarding
the lipid selectivity of interfacial aS binding. The affinity
of the monomeric protein for packing defects in a phospho-
lipid bilayer (19), and the observation that membrane-assis-
ted binding and folding occurs in the presence of vesicles
containing sphingomyelin and cholesterol, with a known
tendency to undergo lateral phase separation (35–37),
underscores the need for additional research. Sphingomye-
lin and cholesterol are abundant in synaptic vesicle
membranes (38) and have also been found in Lewy bodies
(39), suggesting that lipid domains (rafts) could provide
a platform for aS lipid binding (40). Here we use a combina-
tion of circular dichroism (CD) spectroscopy and isothermal
titration calorimetry (ITC) to establish the role of the
N-terminus for membrane-assisted binding and folding of
the monomeric protein. Membrane-assisted folding an
intrinsic property of aS; notably the high folding propensity
of the short N-terminal sequence comprising residues 1–25
suggests that nucleation of the cooperative coil/helix tran-
sition of the adjacent large protein domains emerges from
the amino-terminus of the protein.METHODS
Circular dichroism spectra were recorded with a model No. 810 spectropo-
larimeter (JASCO, Gross Umstadt, Germany). The experiments were
carried out using a quartz cell with 0.2-cm pathlength. Far-ultraviolet
spectra for the 25-amino-acid fragments were recorded from 260–200 nm,
and the signal/noise ratio was improved by accumulating and averaging
four scans. Spectra for the 1–20 peptide were collected on a DSM 20
double-beam spectropolarimeter (Olis, Bogart, GA) with the same path-
length cell from 300 to 190 nm for both low and high salt conditions, at
a rate of 0.25 nm s2 for three scans. The temperature on each spectrometer
was controlled within an accuracy of 50.5C. For the spectra of the
peptides bound to vesicles, the lineshapes of the vesicles alone in buffer
were acquired at each temperature and then subtracted. Calculation of the
helicity was performed as described previously (19). Briefly,
fhelix ¼ ð½Q222  ½QcoilÞ=ð½Qhelix  ½QcoilÞ; where % helicity¼ 100 fhelix.
The mean-residue ellipticities at 222 nm for the completely unfolded and
completely folded peptides were obtained from ½Qcoil ¼ 640 45 T=C
and ½Qhelix ¼ 40; 000ð1 2:5=nÞ þ 100 T=C; where n equals the
number of amino acids in the polypeptide (41).
Isothermal titration calorimetry measurements were performed with
a VP-ITC instrument (MicroCal, Northampton, MA). Typically, 40 injec-
tions of 7 mL each were performed into the calorimeter chamber containing
1.41 mL of the protein or peptide solution. The data were processed usingthe software ORIGIN (MicroCal), and thermodynamic parameters were
determined from the sigmoidal titration curves, assuming independent satu-
rable binding sites in the outer vesicle interface. First, the ligand concentra-
tion was equated with the total lipid concentration in the syringe, neglecting
the aggregation state of the lipids. Second, N independent lipid binding sites
on the protein were assumed (19). The fractional occupancy of lipid-
binding sites on the protein can be obtained from the total heat released,
which is a function of N, the microscopic binding constant Kb, and the
change in enthalpy. The number N can be identified with the total lipids
associated with one protein molecule. This yields the enthalpy per mole
of protein, and a single macroscopic binding constant Kb. Details of the
calculation are described elsewhere (19).RESULTS
Membrane-assisted folding of N-terminal
a-synuclein peptides is revealed by circular
dichroism spectroscopy
Small peptides and larger truncated protein variants were
selected from the aS primary sequence to investigate the
initiation of the structural transition from an unfolded into
a membrane-associated helical state (Fig. 1). The fragments
were selected so as to cover sequence domains that have
been previously shown to be critical for aggregation of
the protein (42), or for the coil/helix transition induced
upon contact with membranes or with detergent micelles
(25,43–46). Fig. 1 summarizes the peptides and the trun-
cated proteins used in this study and their correlation with
previously identified sequence domains.
Circular dichroism spectroscopy, using the ellipticity at
222 nm, reliably detects the transition from a random coil
to a helical peptide conformation as long as no other confor-
mations are involved. Here we assessed interactions of the
aS-derived peptides with SUVs containing lipids with
acidic headgroups, lipids with zwitterionic headgroups
below the chain melting phase transition temperature (Tm)
of the acyl chains, and lipid mixtures—with and without
net surface charges—that undergo phase separation. The
first peptide to be studied was the N-terminal amino-acid
sequence 1–20. This aS fragment has no net charge at
neutral pH and comprises one of the seven repeat motifs
(KTKEGV; see Fig. 1). The peptide was mixed in the
cuvette of the CD spectrometer with SUVs consisting of
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) at
a phospholipid/peptide molar ratio of RL/P ¼ 167. These
vesicles alone undergo a broad thermal transition centered
at 39C due to packing stress in the curved membrane,
rather than 41C as found for multilamellar dispersions.Biophysical Journal 99(7) 2116–2124
2118 Bartels et al.An affinity of full-length aS for packing defects in such
vesicles has recently been discovered by combining CD
spectroscopy and isothermal titration calorimetry (19,35).
Far-ultraviolet CD spectra (47) were recorded over
a temperature range from 45 to 20C, either with 10 mM
phosphate buffer alone (pH 7.0), or with the same buffer
in the presence of 140 mM KCl (Fig. 2, A and B, respec-
tively). These temperature downscans reveal a change in
ellipticity that is most prominent at 222 nm, indicating
that there is, to some extent, a transition from a random-
coil to a helical conformation. Notably, the conformational
transition occurs over the temperature interval from 32 to
20C (i.e., it commences below the phase transition of the
vesicles). This may be contrasted to the more-abrupt confor-
mational change that occurs close to the lipid phase-transi-
tion temperature when monomeric full-length aS interacts
with DPPC vesicles (19). Isodichroic points at 202 nm can
be recognized, both in the presence of low and high ionic
strength, suggesting that there are just two interconverting
peptide conformers in the temperature range of the confor-
mational transition of the 1–20 peptide.
Next, we studied the interaction of the 1–20 peptide with
SUVs comprising an equimolar mixture of DPPC and 1,2-
dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG). These
lipids mix almost ideally in the liquid-crystalline state of
the vesicles, according to the narrow heat capacity peak at
39C. Hence, there are two contributions to the interfacial
lipid-peptide interaction below the phase transition temper-
ature. These are the negative surface charges provided byBiophysical Journal 99(7) 2116–2124the phosphoglycerol headgroups, and the interfacial stress
due to lipid freezing in the highly curved vesicle membrane
(19). The peptide indeed undergoes a coil/helix transition
in the presence of these vesicles (Fig. 2, C and D). At low
ionic strength the electrostatic interaction seems to prevail,
because there is no sudden change of the mean-residue ellip-
ticity [Q]222 that can be correlated with lipid chain melting
(Fig. 2 C). Instead, the spectra change continuously with
decreasing temperature, and a well-defined isodichroic
point is obtained.
Increasing the ionic strength has a strong effect on the
lipid interaction of the peptide (Fig. 2 D); i.e., the CD
spectra now reflect the lipid phase transition, similar to the
result obtained with DPPC alone, as shown in Fig. 2, A
and B. At 20C, the ellipticity minimum at 222 nm and
a prominent minimum at 205 nm indicate that, upon electro-
static shielding, there is even less helical folding than in the
presence of DPPC vesicles (Fig. 2 B). Considering that the
1–20 sequence has no net charge at neutral pH, it must be
concluded that the positive and negative amino-acid charges
(K6, K10, K12, and D2, E13, E20, respectively) are asym-
metrically distributed, so as to enable an optimal interaction
of the positive lysine side chains with the negative lipid
headgroups. A helical-wheel representation indeed shows
the uneven distribution of charged and uncharged amino
acids (Fig. 3). As a result, we propose that the nonpolar
side of the helix immerses into the lipid interface with the
lysines being in close contact with the PG headgroups and
the aspartate and glutamate side chains facing the aqueousFIGURE 2 Temperature dependence of circular
dichroism spectra reveals membrane binding and
coil/helix transition of N-terminal peptide 1–20.
Vesicle compositions: (A) DPPC; (B) DPPC,
140 mM NaCl; (C) DPPC/DPPG (1:1); and (D)
DPPC/DPPG (1:1), 140 mM NaCl. All samples
contained 10 mM Na phosphate, pH 7.0. Total
phospholipid concentration was 5 mM and the
peptide concentration was 30 mM in a cuvette
of 0.2-cm pathlength. CD spectra in terms of
decreasing ellipticity at 222 nm were recorded at
temperatures of 46, 42, 40, 38, 36, 32, 28, 24,
and 20C. Control spectra acquired without
peptide, but with the same buffer and phospholipid
concentration, were subtracted for each tempera-
ture.
FIGURE 3 Helical-wheel representation of 1–25 and 31–55 peptides.
View is from the N-terminus down the helix axis. Adjacent amino acids
are offset by an angle of 100 deg. Residue designations are (yellow) first
amino acid in the sequence; (red) negative amino acid charges; (blue) posi-
tive amino acid charges; (white) slightly polar, neutral amino acids; and
(black) nonpolar, hydrophobic amino acids. Note the opposing lysine clus-
ters, separated by 200 deg (K10, K21, and K12, K23 for the 1–25 peptide,
and K32, K43 and K34, K45 for the 31–55 peptide, respectively).
Membrane Folding of a-Synuclein 2119phase. It follows that the axis of this sided-helix can be
assumed to run parallel with the membrane surface. This
is in full agreement with the structure elucidated in the
simulations of Perlmutter et al. (30).
The mean-residue ellipticity obtained for the 1–20
peptide in the presence of DPPC/DPPG vesicles at 20C
and low ionic strength (see Fig. 2 C) yields a helicity of
69% (see Methods). This may be due either to an imperfect
folding in the bound state, assuming that all of the peptide is
bound, or to the presence of unbound peptide in equilibrium
with a bound portion. To address this problem, isothermalFIGURE 4 Isothermal titration calorimetry yields percentage of vesicle-boun
calorimeter cell containing the peptide or protein solutions. Single 7-mL injectio
(B) 8.5 mMpeptide 6–115 in phosphate buffer, pH 7.0, titrated with DPPC/DPPG
40 mM. (C) Here, 8.7 mM aS titrated with 45 mM DPPC/DPPG vesicles; othe
binding constants Kb were obtained using the binding model for N independent stitration calorimetry was used (Fig. 4 A) which yielded
N ¼ 78 lipid molecules associated with one peptide mole-
cule. A single macroscopic binding constant Kb ¼ 1.02 
106 M–1 is obtained, which characterizes the association
of the N lipids with the peptide molecule, provided that
the peptide-lipid binding equilibrium can be described by
P þ Lc ¼ PLc, where P is the peptide and Lc the virtual
cluster of N lipids associated with the protein (see Methods
for details) (19). The percentage of vesicle-associated
peptide, PLc, can be calculated from this binding equilib-
rium (48). For the experiment shown in Fig. 2 C (total
protein and lipid concentrations, 30 mM and 5 mM, respec-
tively), it turns out that the bound portion of the peptide
amounts to 97.3%. Considering the helicity of 69% this
indicates that a considerable portion of the 1–20 peptide
remains disordered, even when almost all of the peptide is
lipid-associated. Similarly, ITC yielded 99.9% binding for
the full-length protein at the same temperature and total
lipid/protein ratio (Fig. 4 C), although the helicity was
only 48% (see Fig. 5) (19).Peptide fragments reveal the modular
organization of full-length a-synuclein
Overlapping aS fragments, ranging from 25 to 28 residues,
were studied next, allowing us to scan the aS sequence for
membrane-mediated helix folding. Peptides were selected
so as to cover the aS sequence up to residue 85. Experi-
mental conditions (100 mM KCl, pH 7.4) were chosen to
be close to those of the intracellular milieu. Here we showd peptide or protein. SUV suspensions were titrated at 20C into a 1.4-mL
n volumes were typically employed. (A) Here, 30 mM of peptide 1–20 and
vesicles; molar ratio of the lipids 1:1, total lipid concentration in the syringe,
r conditions as in panels A and B. The number of associated lipids and the
ites provided with the software ORIGIN (MicroCal). (For details, see (19).)
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FIGURE 5 Circular dichroism spectroscopymanifests helical folding due
to local sequence properties and lipid composition of vesicle membranes.
The helicity was obtained from mean-residue ellipticity values at 222 nm.
Small unilamellar vesicles (phospholipid concentration 5 mM) and aS or
aS-derived peptides in 100 mM KCl, 20 mM Na phosphate, pH 7.4, were
mixed in a 0.2-cm pathlength CD cuvette, and incubated for 5 min to
allow for temperature equilibration. The molar ratio of phospholipids in
the binary mixtures was 1:1 and the lipid/protein (peptide) molar ratio was
167:1. Temperature, 20C; typical errors56%. (Methods).
2120 Bartels et al.the helicity (Fig. 5) as obtained from the mean-residue ellip-
ticity values at 222 nm at 20C (see Methods). This simpli-
fying approach seems justified, as deconvolution of the
spectra (49) typically yielded <15% of contributions from
structures other than helix or coil. We cannot rule out that
a larger fraction of extended b-structure contributes to the
CD spectra in cases where deconvolution is not feasible
due to poor signal/noise. However, we believe that the
temperature dependence of the spectra reflects an increasing
contribution of helical folding with decreasing temperature,
particularly if the temperature scans involve a lipid chain
melting phase transition. There is a distinct propensity
for helix formation of the full-length protein and the
1–25 fragment, triggered by contact with any of the vesic-
ular membranes shown in Fig. 5. In contrast, the 1–20
peptide does not fold in the presence of the liquid-crystalline
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)/
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG)
vesicles, but does so, although to a lesser extent, in the pres-
ence of DPPC vesicles below the chain melting phase transi-
tion temperature. The 31–55 peptide has even less helix
propensity in the presence of vesicles comprising POPC/
POPG or DPPC alone, though it exhibits a surprising affinity
for the DPPC/DPPG interface. This peptide incorporates
three positive net charges (includingH50) and twoKTKEGV
motifs. The particular arrangement of these residues along
the helical circumference allows for strong simultaneous
charge and hydrophobic interactions in the disordered defectBiophysical Journal 99(7) 2116–2124zones of the DPPC/DPPG vesicle interface below the transi-
tion temperature.
These results clearly show that the N-terminal peptides
not only respond to electrostatic forces, but also to packing
defects in the vesicular membrane. Separation of these
contributions can be achieved by monitoring the tempera-
ture dependence of the coil/helix transition in the pres-
ence of the different vesicles (Fig. 6). For comparison, the
temperature dependence of the mean-residue ellipticity of
the full-length aS protein is included (Fig. 6 A). In the pres-
ence of vesicles consisting of DPPC alone, the full-length
protein undergoes helix folding in the temperature range
of the chain melting transition of the vesicles, in accord
with previous findings (19). By contrast, the negative
surface charge of POPC/POPG vesicles results in a partially
folded protein over the entire temperature range (18). In
DPPC/DPPG vesicles, the negative headgroup charges give
rise to mean-residue ellipticities similar to those obtained
in the presence of the POPC/POPG mixture. A further
decrease to more negative ellipticity values occurs at the
transition temperature, which is in line with a cumulative
effect of electrostatic interactions and interfacial packing
defects.
The temperature dependence of the membrane-induced
coil/helix transition of the 1–25 peptide is similar to the
thermal behavior of the full-length protein, but surprisingly
different from the 31–55 peptide (Fig. 6, B and C). Peptide
1–25, similar to aS itself, assumes a helix (~30% helicity)
when mixed with POPC/POPG vesicles in a temperature-
independent manner, while the strong temperature depen-
dence in the presence of DPPC/DPPG vesicles is clearly
related to the chain melting phase transition. The phase tran-
sition in the presence of DPPC vesicles alone induces
a similar conformational change, but over a much broader
temperature range than for the full-length protein. In
contrast, the 31–55 fragment does not undergo helix folding
in the presence of the liquid-crystalline POPC/POPG vesi-
cles, and DPPC vesicles are only able to elicit a small effect
at temperatures far from the lipid phase-transition tempera-
ture (Fig. 6 C). The interaction with DPPC/DPPG vesicles,
however, is surprisingly strong for this peptide, and the
coil/helix transition commences in the temperature range
where lipid chain melting occurs. The mean-residue
ellipticity of –21,000 deg cm2 dmol–1 obtained at 20C
during a temperature downscan (which translates into 61%
helicity) clearly exceeds the values reached by the other
peptides, except for the 1–25 sequence. Evidently, there is
a nearly perfect match when the 31–55 peptide helix dips
into the molecularly rough interface of the curved gel-state
DPPC/DPPG vesicles, which arises from the dislocation
stress field. However, there may be no such opportunity for
the POPC/POPG vesicles with a liquid-crystalline interface
relatively free of defects. Specifically, the lysine residues
within the KTK motifs are offset by ~200 deg, which puts
them on opposite sides of the a-helix as depicted by the
FIGURE 6 Temperature dependence of mean-residue ellipticity at
222 nm reveals varying affinities of N-terminal sequence domains to
surface charges and membrane defects. (A) Full-length a-synuclein, (B)
1-25 peptide, and (C) 31-35 peptide. Small unilamellar vesicles (phospho-
lipid concentration 5 mM) were mixed with 6 mM aS or 30 mM of the
peptides in 100 mM KCl, 20 mM Na phosphate, pH 7.4, corresponding
to phospholipid/protein molar ratios of 833:1 and 167:1. The molar ratio
of phospholipids in the binary mixtures was 1:1. The temperature range
of the phase transition for DPPC and DPPC/DPPG vesicles is indicated
by the hatched area. Note the additive effect of electrostatic interaction
and chain melting phase transition on the mean-residue ellipticity of the
full-length protein and the 1–25 peptide.
Membrane Folding of a-Synuclein 2121helical wheel in Fig. 3. This spatial arrangement may allow
for proper positioning of the helix due to interaction of the
positive amino-acid charges with the negative surface poten-
tial of the membrane, thereby dragging the nonpolar residues
of the sided helix deeper into the membrane interface.FIGURE 7 Stepwise removal of N-terminal amino acids from a-synu-
clein yields a progressive decrease of membrane-induced helical folding.
Mean-residue ellipticities of SUVs were determined in 20 mM sodium
phosphate, pH 7.4, and 100 mM KCl. Total SUV lipid concentration was
5 mM; protein concentrations were 8.5 mM and 6 mM for the deletion
and truncation mutants, corresponding to lipid/protein molar ratios of 588
and 833, respectively. The molar ratio of phospholipids in the binary
mixtures was 1:1. Temperature, 20C.The N-terminus triggers interfacial binding
and helix folding of full-length a-synuclein
Next, we constructed a number of truncated aS variants by
stepwise removal of residues from the N-terminus, as well
as two fragments that lacked the acidic C-terminal tailof the protein (Fig. 7). Various lipid compositions were
studied, including a mixture of neutral lipids that undergoes
lateral phase separation (36). There was always a stoichio-
metric excess of the vesicles, i.e., the total lipid/protein
molar ratios were RL/P ¼ 588 (for the aS deletion mutants)
or RL/P ¼ 833 (for the chemically truncated or for the full-
length protein), which is more than twice the saturation ratio
as determined by CD or ITC titration (19). The largest
absolute mean-residue ellipticities were obtained with the
1–115 protein variant for all lipid mixtures shown in
Fig. 7. Perhaps this is not surprising if one considers that
the C-terminal sequence domain does not take part in the
helix folding of the full-length protein (50). Assuming that
the truncated sequence reaches the same extent of helix
folding as the full-length protein, one may expect that the
mean-residue ellipticity increases by ~18%. However, the
ellipticity was only ~5% larger than the value obtained for
full-length aS, probably due to some disorder in the new
C-terminus after removal of 25 residues. In addition to these
end effects, there may be a loss of stabilization of the protein
structure, owing to an interaction between the C-terminus of
aS and the central hydrophobic domain of the protein (51)
(see Discussion).
The salient feature of Fig. 7 is the systematic reduction
of the membrane-induced mean-residue ellipticity upon
stepwise truncation of the N-terminus. This suggests that
the N-terminal amino acids are essential for membrane
recognition and for the initiation of the folding of the entire
protein. Even removal of the first two N-terminal amino
acids (methionine and aspartate) has a remarkably strong
effect in membranes with a mixed lipid composition. TheseBiophysical Journal 99(7) 2116–2124
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sition is an intrinsic feature of the N-terminal protein
sequence, independent of the particular properties of the
membrane interface. The low mean-residue ellipticity of
the 6–115 fragment obtained with any of the vesicle
membranes is also in excellent agreement with the notion
that the N-terminus determines the folding of the full-length
protein. Isothermal titration calorimetry at 20C yielded
N ¼ 123 for the lipids associated with one protein molecule
and a binding constant Kb ¼ 2.2  106 M–1 (see Fig. 4 B),
which gives 99% binding when allowance is made for the
protein and lipid concentrations pertinent to the CD experi-
ment. The helicity of 19% obtained under the same condi-
tions (see Fig. 7) suggests that there is even more disorder
in the membrane-bound state of this truncated version of
aS than in the bound full-length protein. Comparing this
with the result obtained for the 1–115 fragment (helicity
51%), it is obvious that the five N-terminal amino acids
are critical for the folding of the protein, regardless of the
high folding propensity of the downstream peptide 31–55
(see Figs. 6 and 7).DISCUSSION
Membrane affinity and helix formation is intrinsic
to the N-terminus of a-synuclein
The results presented here afford new insights into the
structural properties of the various aS sequence motifs.
The conformational transition of aS is triggered by the
N-terminus, as shown by the membrane affinity and helix
propensity of the 1–25 peptide fragment, rather than by being
a function of cooperative all-or-none folding of the entire
protein. Moreover, our data suggest that the 1–25 peptide
features a similar selectivity for different lipid compositions
as the full-length protein. Notably, the adjacent 9–36
sequence that is part of the NMR-derived N-terminal helix
formed in the presence of SDS micelles (25) is much less
prone to undergo a spontaneous conformational transition
at a membrane interface. Membrane-induced helix folding
is negligible in the presence of POPC/POPG vesicles for all
peptides shown in Fig. 5, except for the 1–25 fragment.
Only the 1–25 and 1–20 peptides respond to the electroneu-
tral defect interface of gel-state DPPC vesicles. Hence, the
N-terminus triggers the coil/helix transition of the protein
in different membranes.
The low affinity of the 1–20 peptide for the POPC/POPG
interface is not surprising, because this peptide has no net
charge. The 1–20 peptide was chosen to demonstrate that
even weak interaction with a defective membrane interface,
in the absence of strong electrostatic forces, leads to partial
helix folding. There are, however, positive side-chain
charges in excess over negative ones for the 9–36, 31–55,
and 41–65 peptides (two, two, and one, respectively).
Hence, the mere charge excess is not sufficient forBiophysical Journal 99(7) 2116–2124membrane recognition and helix folding of these fragments.
Rather, it must be assumed that there is a slight preponder-
ance of partially folded structures in the ensemble of rapidly
interconverting conformations, which makes the 1–25
peptide more adapted to recognize the lipid interface than
the C-terminal segments. This peptide selectivity is in qual-
itative agreement with a recent NMR study, which demon-
strated preferential lipid binding and folding for the N-
terminal sequence of the full-length protein (52).Packing defects and membrane surface potential
are determinants of a-synuclein binding
Notably, there is a high proclivity of the peptides for the
folded state in the presence of the DPPC/DPPG vesicles.
This lipid mixture provides two favorable properties simul-
taneously, i.e., packing defects and negative surface charges.
The accessibility of the hydrophobic membrane core is
evidently crucial for both hydrophobic and electrostatic
contact of the extended full-length protein helix (27). The
detrimental effect of aS oligomers on bilayer integrity
indeed conforms with this paradigm (53). In contrast to
aS oligomers, however, binding of the monomeric protein
results in stabilization of a defective interface (19,35).
Further support comes from the observation that the full-
length protein and peptide 1–25 are able to reduce the
calcium or detergent-induced fusion of small unilamellar
vesicles (see Fig. S1 in the Supporting Material). A recent
study, demonstrating that overexpression of aS in a primary
hippocampal cell culture results in considerable inhibition
of neurotransmitter release (54), is also in line with a retard-
ing effect of aS upon vesicle fusion. The reduced clustering
of synaptic vesicles near the active zone observed by these
authors may indeed be related to the observed inhibition
of in vitro vesicle fusion as aS stabilizes the synaptic vesicle
reserve pool (1,19).
The strong interaction of the 31–55 peptide with gel-state
DPPC/DPPG vesicles seems surprising, considering the
broken-helix model that has emerged from previous high-
resolution NMR studies. In the presence of SDS micelles,
the protein forms two antiparallel helices connected by
a hinge region that comprises most of the residues of this
peptide (24,25,46,55). However, a contiguous helix—
comprising at least residues 3–90—exists in a vesicular
membrane interface with a much larger radius of curvature
than a micelle (27). Evidently, the membrane-stabilizing
effect of aS requires that almost two-thirds of the primary
sequence of the protein be in a helical state to warrant the
optimal interfacial contact, as well as to avoid aggregation
of the most unfolded and hydrophobic central part of the
aS sequence (52). Thus, the hinge may be required for the
protein to adapt to membrane curvature after attachment
and folding of the N-terminal 25 amino acid residues. The
strong tendency for helix formation of the hinge region—
and likewise of peptides 9–36 and 41–65—may come into
Membrane Folding of a-Synuclein 2123play only after nucleation by the N-terminal sequence
domain.
The gradual decrease of the mean-residue ellipticities
upon removal of amino acids from the N-terminus reflects
an intrinsic protein property, because it is alike for different
lipid compositions. This holds true also for vesicles
composed of POPC, sphingomyelin, and cholesterol (molar
ratio 2:2:1), strongly suggesting that the aS binding mode is
the same for this electroneutral interface as for membranes
with net interfacial charges or for vesicles in the gel state.
This lipid mixture is close to the classic (i.e., equimolar)
raft mixture of the three lipids (36), which suggests that
the favorable interaction between cholesterol and sphingo-
myelin results in partial phase separation and microdomain
formation.
Mechanistic aspects and biomedical implications
Finally, a tentative model of aS binding and membrane
interaction can be derived from our results. We hypothesize
that the N-terminus of aS serves as a nucleation center for
membrane binding of the full-length protein and helix
folding up to approximately residue 100. A two-stage model
considers binding of residues 1–25 as the initial step, and
subsequent cooperative binding and folding of residues
26–100 as the second step (52,56). The first state leaves
the protein prone to aggregation due to solvent exposure
and disordering of the most hydrophobic central part of
the protein (52). In the second state, the long helix fold
protects from aggregation, and allows for the full
membrane-stabilizing capacity of the protein (35). Early
aggregates, usually referred to as oligomers, are believed
to represent the real toxic species of the protein. Toxic olig-
omer formation in a membrane interface may be particularly
deleterious for cell viability when it affects intracellular
storage vesicles (34). This attains even greater importance
when one considers that the overwhelming number of
synuclein-related disease cases is idiopathic. The culprit
of the early aggregation then may be an alteration of
membrane properties, e.g., the lipid composition of synaptic
vesicles, rather than a defective protein structure. A subtle
change in the interfacial properties may result in an exten-
sion of the time interval between the hypothetical binding
modes of the protein, which may enhance the chance for
hydrophobic protein-protein contact. Our approach, using
peptide fragments of an intrinsically unstructured protein
as employed here for aS, not only simplifies the elucidation
of the initial events that lead to protein aggregation or
folding in a membrane interface, but also may be useful
for rational drug design and for the design of rapid drug
screening methodology.SUPPORTING MATERIAL
One figure and additional methods are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(10)00778-2.We thank Ulf Dettmer and Lucas Martin for technical advice in preparing
the deletion mutants and John Fitch and Chad Park for helpful discussions
regarding CD spectroscopy and ITC.
This work was supported by the Arizona Biomedical Research Foundation,
the Deutsche Forschungsgemeinschaft (under grant No. SFB 596, Teilpro-
jekt No. B10), and the National Institutes of Health, Bethesda, MD.REFERENCES
1. Beyer, K. 2007. Mechanistic aspects of Parkinson’s disease: a-synu-
clein and the biomembrane. Cell Biochem. Biophys. 47:285–299.
2. Haass, C., and D. J. Selkoe. 2007. Soluble protein oligomers in neuro-
degeneration: lessons from the Alzheimer’s amyloid b-peptide. Nat.
Rev. Mol. Cell Biol. 8:101–112.
3. Dev, K. K., K. Hofele,., H. van der Putten. 2003. Part II: a-synuclein
and its molecular pathophysiological role in neurodegenerative disease.
Neuropharmacology. 45:14–44.
4. Moore, D. J., A. B. West, ., T. M. Dawson. 2005. Molecular patho-
physiology of Parkinson’s disease. Annu. Rev. Neurosci. 28:57–87.
5. Wakabayashi, K., M. Yoshimoto,., H. Takahashi. 1998. a-synuclein
immunoreactivity in glial cytoplasmic inclusions in multiple system
atrophy. Neurosci. Lett. 249:180–182.
6. Gai, W. P., J. H. T. Power,., W. W. Blessing. 1998. Multiple-system
atrophy: a new a-synuclein disease? Lancet. 352:547–548.
7. Spillantini, M. G., M. L. Schmidt,., M. Goedert. 1997. a-synuclein in
Lewy bodies. Nature. 388:839–840.
8. Goedert, M. 2001. Alpha-synuclein and neurodegenerative diseases.
Nat. Rev. Neurosci. 2:492–501.
9. Dedmon, M. M., K. Lindorff-Larsen, ., C. M. Dobson. 2005.
Mapping long-range interactions in a-synuclein using spin-label
NMR and ensemble molecular dynamics simulations. J. Am. Chem.
Soc. 127:476–477.
10. Polymeropoulos, M. H., C. Lavedan,., R. L. Nussbaum. 1997. Muta-
tion in the a-synuclein gene identified in families with Parkinson’s
disease. Science. 276:2045–2047.
11. Kru¨ger, R., W. Kuhn, ., O. Riess. 1998. Ala30Pro mutation in the
gene encoding a-synuclein in Parkinson’s disease. Nat. Genet.
18:106–108.
12. Zarranz, J. J., J. Alegre,., J. G. de Yebenes. 2004. The new mutation,
E46K, of a-synuclein causes Parkinson and Lewy body dementia. Ann.
Neurol. 55:164–173.
13. Conway, K. A., S.-J. Lee,., P. T. Lansbury, Jr. 2000. Acceleration of
oligomerization, not fibrilization, is a shared property of both a-synu-
clein mutations linked to early-onset Parkinson’s disease: implications
for pathogenesis and therapy. Proc. Natl. Acad. Sci. USA. 97:571–576.
14. Han, H., P. H. Weinreb, and P. T. Lansbury, Jr. 1995. The core Alz-
heimer’s peptide NAC forms amyloid fibrils which seed and are seeded
by b-amyloid: is NAC a common trigger or target in neurodegenerative
disease? Chem. Biol. 2:163–169.
15. Surewicz, W. K., R. M. Epand,., S. W. Hui. 1986. Human apolipo-
protein A-I forms thermally stable complexes with anionic but not
with zwitterionic phospholipids. J. Biol. Chem. 261:16191–16197.
16. Segrest, J. P., M. K. Jones, ., G. M. Anantharamaiah. 1992. The
amphipathic helix in the exchangeable apolipoproteins: a review of
secondary structure and function. J. Lipid Res. 33:141–166.
17. Ajees, A. A., G. M. Anantharamaiah,., H. M. Murthy. 2006. Crystal
structure of human apolipoprotein A-I: insights into its protective effect
against cardiovascular diseases. Proc. Natl. Acad. Sci. USA. 103:
2126–2131.
18. Davidson, W. S., A. Jonas, ., J. M. George. 1998. Stabilization of
a-synuclein secondary structure upon binding to synthetic membranes.
J. Biol. Chem. 273:9443–9449.
19. Nuscher, B., F. Kamp, ., K. Beyer. 2004. a-synuclein has a high
affinity for packing defects in a bilayer membrane: a thermodynamics
study. J. Biol. Chem. 279:21966–21975.Biophysical Journal 99(7) 2116–2124
2124 Bartels et al.20. Gallop, J. L., C. C. Jao, ., H. T. McMahon. 2006. Mechanism of
endophilin N-BAR domain-mediated membrane curvature. EMBO J.
25:2898–2910.
21. Itoh, T., and T. Takenawa. 2009. Mechanisms of membrane deforma-
tion by lipid-binding domains. Prog. Lipid Res. 48:298–305.
22. Botelho, A. V., T. Huber,., M. F. Brown. 2006. Curvature and hydro-
phobic forces drive oligomerization and modulate activity of rhodopsin
in membranes. Biophys. J. 91:4464–4477.
23. Fink, A. L. 2006. The aggregation and fibrillation of a-synuclein. Acc.
Chem. Res. 39:628–634.
24. Chandra, S., X. Chen, ., T. C. Su¨dhof. 2003. A broken a-helix in
folded a-synuclein. J. Biol. Chem. 278:15313–15318.
25. Ulmer, T. S., A. Bax, ., R. L. Nussbaum. 2005. Structure and
dynamics of micelle-bound human a-synuclein. J. Biol. Chem.
280:9595–9603.
26. Georgieva, E. R., T. F. Ramlall,., D. Eliezer. 2008. Membrane-bound
a-synuclein forms an extended helix: long-distance pulsed ESR
measurements using vesicles, bicelles, and rodlike micelles. J. Am.
Chem. Soc. 130:12856–12857.
27. Jao, C. C., B. G. Hegde,., R. Langen. 2008. Structure of membrane-
bound a-synuclein from site-directed spin labeling and computational
refinement. Proc. Natl. Acad. Sci. USA. 105:19666–19671.
28. Drescher, M., G. Veldhuis, ., M. Huber. 2008. Antiparallel arrange-
ment of the helices of vesicle-bound a-synuclein. J. Am. Chem. Soc.
130:7796–7797.
29. Bodner, C. R., C. M. Dobson, and A. Bax. 2009. Multiple tight phos-
pholipid-binding modes of a-synuclein revealed by solution NMR
spectroscopy. J. Mol. Biol. 390:775–790.
30. Perlmutter, J. D., A. R. Braun, and J. N. Sachs. 2009. Curvature
dynamics of a-synuclein familial Parkinson disease mutants: molec-
ular simulations of the micelle- and bilayer-bound forms. J. Biol.
Chem. 284:7177–7189.
31. Liu, C. W., B. I. Giasson,., P. J. Thomas. 2005. A precipitating role
for truncated a-synuclein and the proteasome in a-synuclein aggrega-
tion: implications for pathogenesis of Parkinson disease. J. Biol. Chem.
280:22670–22678.
32. Bertoncini, C. W., Y. S. Jung, ., M. Zweckstetter. 2005. Release of
long-range tertiary interactions potentiates aggregation of natively
unstructured a-synuclein. Proc. Natl. Acad. Sci. USA. 102:1430–1435.
33. Tamamizu-Kato, S., M. G. Kosaraju, ., V. Narayanaswami. 2006.
Calcium-triggered membrane interaction of the a-synuclein acidic
tail. Biochemistry. 45:10947–10956.
34. Vamvaca, K., M. J. Volles, and P. T. Lansbury, Jr. 2009. The first
N-terminal amino acids of a-synuclein are essential for a-helical struc-
ture formation in vitro and membrane binding in yeast. J. Mol. Biol.
389:413–424.
35. Kamp, F., and K. Beyer. 2006. Binding of a-synuclein affects the lipid
packing in bilayers of small vesicles. J. Biol. Chem. 281:9251–9259.
36. Bartels, T., R. S. Lankalapalli, ., M. F. Brown. 2008. Raftlike
mixtures of sphingomyelin and cholesterol investigated by solid-state
2H NMR spectroscopy. J. Am. Chem. Soc. 130:14521–14532.
37. Bunge, A., P. Mu¨ller, ., D. Huster. 2008. Characterization of the
ternary mixture of sphingomyelin, POPC, and cholesterol: support
for an inhomogeneous lipid distribution at high temperatures. Biophys.
J. 94:2680–2690.
38. Takamori, S., M. Holt,., R. Jahn. 2006. Molecular anatomy of a traf-
ficking organelle. Cell. 127:831–846.Biophysical Journal 99(7) 2116–212439. Gai, W. P., H. X. Yuan,., P. H. Jensen. 2000. In situ and in vitro study
of colocalization and segregation of a-synuclein, ubiquitin, and lipids
in Lewy bodies. Exp. Neurol. 166:324–333.
40. Cooper, A. A., A. D. Gitler, ., S. Lindquist. 2006. Alpha-synuclein
blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s
models. Science. 313:324–328.
41. Scholtz, J. M., H. Qian,., R. L. Baldwin. 1991. Parameters of helix-
coil transition theory for alanine-based peptides of varying chain
lengths in water. Biopolymers. 31:1463–1470.
42. Uversky, V. N., and A. L. Fink. 2002. Amino acid determinants of
a-synuclein aggregation: putting together pieces of the puzzle. FEBS
Lett. 522:9–13.
43. Eliezer, D., E. Kutluay,., G. Browne. 2001. Conformational proper-
ties of a-synuclein in its free and lipid-associated states. J. Mol. Biol.
307:1061–1073.
44. Bussell, Jr., R., and D. Eliezer. 2003. A structural and functional role
for 11-mer repeats in a-synuclein and other exchangeable lipid binding
proteins. J. Mol. Biol. 329:763–778.
45. Bisaglia, M., I. Tessari, ., S. Mammi. 2005. A topological model of
the interaction between a-synuclein and sodium dodecyl sulfate
micelles. Biochemistry. 44:329–339.
46. Ulmer, T. S., and A. Bax. 2005. Comparison of structure and dynamics
of micelle-bound human a-synuclein and Parkinson disease variants.
J. Biol. Chem. 280:43179–43187.
47. Brown, M. F., and T. Schleich. 1975. Circular dichroism and gel filtra-
tion behavior of subtilisin enzymes in concentrated solutions of guani-
dine hydrochloride. Biochemistry. 14:3069–3074.
48. Jia, Z., T. Ramstad, and M. Zhong. 2002. Determination of protein-
drug binding constants by pressure-assisted capillary electrophoresis
(PACE)/frontal analysis (FA). J. Pharm. Biomed. Anal. 30:405–413.
49. Provencher, S. W., and J. Glo¨ckner. 1981. Estimation of globular
protein secondary structure from circular dichroism. Biochemistry.
20:33–37.
50. Der-Sarkissian, A., C. C. Jao,., R. Langer. 2003. Structural organiza-
tion of a-synculein fibrils by site-directed spin labeling. J. Biol. Chem.
278:37530–37535.
51. McClendon, S., C. C. Rospigliosi, and D. Eliezer. 2009. Charge
neutralization and collapse of the C-terminal tail of a-synuclein at
low pH. Protein Sci. 18:1531–1540.
52. Bodner, C. R., A. S. Maltsev,., A. Bax. 2010. Differential phospho-
lipid binding of a-synuclein variants implicated in Parkinson’s disease
revealed by solution NMR spectroscopy. Biochemistry. 49:862–871.
53. van Rooijen, B. D., M. M. Claessens, and V. Subramaniam. 2009. Lipid
bilayer disruption by oligomeric a-synuclein depends on bilayer charge
and accessibility of the hydrophobic core. Biochim. Biophys. Acta.
1788:1271–1278.
54. Nemani, V. M., W. Lu,., R. H. Edwards. 2010. Increased expression
of a-synuclein reduces neurotransmitter release by inhibiting synaptic
vesicle reclustering after endocytosis. Neuron. 65:66–79.
55. Bortolus, M., F. Tombolato,., A. L. Maniero. 2008. Broken helix in
vesicle and micelle-bound a-synuclein: insights from site-directed spin
labeling-EPR experiments and MD simulations. J. Am. Chem. Soc.
130:6690–6691.
56. Ferreon, A. C. M., Y. Gambin,., A. A. Deniz. 2009. Interplay of a-
synuclein binding and conformational switching probed by single-
molecule fluorescence. Proc. Natl. Acad. Sci. USA. 106:5645–5650.
